Search Results

We hope you find what you’re looking for. You can email us if you need additional help.

Shareholder Update: May 4, 2023

Dear Valued Shareholders, This is the news you’ve been waiting for. Optimi Health today announced that it has entered into a $1.2 million CAD definitive supply agreement with a private entity focused on developing mushroom-based therapeutic drugs through pre-clinical research

Read More »

Products do not contain psilocybin

Get news & updates directly to your inbox.
Interested In Optimi? Let's Talk.